Literature DB >> 29760148

Bacterial Silver Resistance Gained by Cooperative Interspecies Redox Behavior.

Michael Muller1.   

Abstract

Silver has emerged as an important therapeutic option for wound infections in recent years due to its broad-spectrum antimicrobial activity. The silver cation (Ag+), but not the bulk metal (Ag0), is highly toxic for most microorganisms, although resistance due to genetic modification or horizontal gene transfer does occur. Pseudomonas aeruginosa, however, achieves silver resistance by producing the redox-active metabolite pyocyanin that reduces Ag+ to nontoxic Ag0 Pyocyanin also possesses broad-spectrum antimicrobial activity. Many microbial species reduce pyocyanin, which reduces molecular oxygen to antimicrobial hydrogen peroxide. In this study, it was hypothesized that both Ag+ and oxygen would act as competing terminal electron acceptors for pyocyanin, thus acting as a universal microbial protectant from Ag+ while avoiding hydrogen peroxide formation. Escherichia coli and Staphylococcus aureus efficiently reduced pyocyanin and generated hydrogen peroxide, while Ag+ markedly reduced the amount of hydrogen peroxide produced. Although unable to reduce directly Ag+ to Ag0 on their own, E. coli and S. aureus did so when pyocyanin was present, resulting in increased survival when exposed to Ag+ Coincubation experiments with either E. coli or S. aureus with P. aeruginosa demonstrated increased survival for those species to Ag+, but only if pyocyanin was present. These data demonstrate that microorganisms that display no intrinsic silver resistance may survive and proliferate under potentially toxic conditions, provided their environment contains a suitable redox-active metabolite-producing bacterium. Chronic wounds are often polymicrobial in nature, with pyocyanin-producing P. aeruginosa bacteria frequently being present; therefore, redox-based silver resistance may compromise treatment efforts.
Copyright © 2018 American Society for Microbiology.

Entities:  

Keywords:  Escherichia coli; Pseudomonas aeruginosa; Staphylococcus aureus; pyocyanin; silver resistance

Mesh:

Substances:

Year:  2018        PMID: 29760148      PMCID: PMC6105860          DOI: 10.1128/AAC.00672-18

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  34 in total

1.  A new method of preparation of pyocyanin and demonstration of an unusual bacterial sensitivity.

Authors:  M Knight; P E Hartman; Z Hartman; V M Young
Journal:  Anal Biochem       Date:  1979-05       Impact factor: 3.365

2.  Plasmid-determined silver resistance in Pseudomonas stutzeri isolated from a silver mine.

Authors:  C Haefeli; C Franklin; K Hardy
Journal:  J Bacteriol       Date:  1984-04       Impact factor: 3.490

3.  Antibiotic action of pyocyanin.

Authors:  S S Baron; J J Rowe
Journal:  Antimicrob Agents Chemother       Date:  1981-12       Impact factor: 5.191

4.  Multiple bacterial species reside in chronic wounds: a longitudinal study.

Authors:  Kristine Gjødsbøl; Jens Jørgen Christensen; Tonny Karlsmark; Bo Jørgensen; Bjarke M Klein; Karen A Krogfelt
Journal:  Int Wound J       Date:  2006-09       Impact factor: 3.315

5.  Glutathione modulates the toxicity of, but is not a biologically relevant reductant for, the Pseudomonas aeruginosa redox toxin pyocyanin.

Authors:  Michael Muller
Journal:  Free Radic Biol Med       Date:  2011-01-19       Impact factor: 7.376

Review 6.  Why chronic wounds will not heal: a novel hypothesis.

Authors:  Thomas Bjarnsholt; Klaus Kirketerp-Møller; Peter Østrup Jensen; Kit G Madsen; Richard Phipps; Karen Krogfelt; Niels Høiby; Michael Givskov
Journal:  Wound Repair Regen       Date:  2008 Jan-Feb       Impact factor: 3.617

7.  Mechanism of the antibiotic action pyocyanine.

Authors:  H M Hassan; I Fridovich
Journal:  J Bacteriol       Date:  1980-01       Impact factor: 3.490

8.  The effect of bacterial colonization on venous ulcer healing.

Authors:  A R Halbert; M C Stacey; J B Rohr; A Jopp-McKay
Journal:  Australas J Dermatol       Date:  1992       Impact factor: 2.875

9.  Antibacterial activity and mechanism of action of the silver ion in Staphylococcus aureus and Escherichia coli.

Authors:  Woo Kyung Jung; Hye Cheong Koo; Ki Woo Kim; Sook Shin; So Hyun Kim; Yong Ho Park
Journal:  Appl Environ Microbiol       Date:  2008-02-01       Impact factor: 4.792

10.  Pseudomonas aeruginosa Alters Staphylococcus aureus Sensitivity to Vancomycin in a Biofilm Model of Cystic Fibrosis Infection.

Authors:  Giulia Orazi; George A O'Toole
Journal:  MBio       Date:  2017-07-18       Impact factor: 7.867

View more
  9 in total

1.  Biogenic Silver Nanoparticles Strategically Combined With Origanum vulgare Derivatives: Antibacterial Mechanism of Action and Effect on Multidrug-Resistant Strains.

Authors:  Sara Scandorieiro; Bianca C D Rodrigues; Erick K Nishio; Luciano A Panagio; Admilton G de Oliveira; Nelson Durán; Gerson Nakazato; Renata K T Kobayashi
Journal:  Front Microbiol       Date:  2022-05-06       Impact factor: 6.064

2.  Appropriate use of dressings containing nanocrystalline silver to support antimicrobial stewardship in wounds.

Authors:  Emma J Woodmansey; Christopher D Roberts
Journal:  Int Wound J       Date:  2018-08-17       Impact factor: 3.315

3.  Key Parameters on the Antibacterial Activity of Silver Camphor Complexes.

Authors:  Joana P Costa; Sílvia A Sousa; Adelino M Galvão; J Miguel Mata; Jorge H Leitão; M Fernanda N N Carvalho
Journal:  Antibiotics (Basel)       Date:  2021-01-30

Review 4.  Antimicrobial Properties of the Ag, Cu Nanoparticle System.

Authors:  Xinzhen Fan; L'Hocine Yahia; Edward Sacher
Journal:  Biology (Basel)       Date:  2021-02-10

5.  The antimicrobial activity of silver acetate against Acinetobacter baumannii in a Galleria mellonella infection model.

Authors:  Eden Mannix-Fisher; Samantha McLean
Journal:  PeerJ       Date:  2021-04-22       Impact factor: 2.984

Review 6.  Antimicrobial Silver in Medicinal and Consumer Applications: A Patent Review of the Past Decade (2007⁻2017).

Authors:  Wilson Sim; Ross T Barnard; M A T Blaskovich; Zyta M Ziora
Journal:  Antibiotics (Basel)       Date:  2018-10-26

Review 7.  Silver Nanoparticles for the Therapy of Tuberculosis.

Authors:  Alexandru-Flaviu Tăbăran; Cristian Tudor Matea; Teodora Mocan; Alexandra Tăbăran; Marian Mihaiu; Cornel Iancu; Lucian Mocan
Journal:  Int J Nanomedicine       Date:  2020-03-31

8.  Conjugation of Penicillin-G with Silver(I) Ions Expands Its Antimicrobial Activity against Gram Negative Bacteria.

Authors:  Ioannis Ketikidis; Christina N Banti; Nikolaos Kourkoumelis; Constantinos G Tsiafoulis; Christina Papachristodoulou; Angelos G Kalampounias; Sotiris K Hadjikakou
Journal:  Antibiotics (Basel)       Date:  2020-01-13

9.  A Guanosine-Quadruplex Hydrogel as Cascade Reaction Container Consuming Endogenous Glucose for Infected Wound Treatment-A Study in Diabetic Mice.

Authors:  Yuanfeng Li; Linzhu Su; Yongxin Zhang; Yong Liu; Fan Huang; Yijin Ren; Yingli An; Linqi Shi; Henny C van der Mei; Henk J Busscher
Journal:  Adv Sci (Weinh)       Date:  2022-01-22       Impact factor: 16.806

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.